These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 366325)

  • 1. [Evolution towards generalization and cancer of a muco-cutaneous leishmaniasis treated with corticoids. (Report of a Chadian case) (author's transl)].
    Derrien JP; Dedet JP; Vedy J; Delpy P; Sirol J
    Med Trop (Mars); 1978; 38(4):447-51. PubMed ID: 366325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cutaneous leishmaniasis followed by kala-azar in an adult in the province of Teramo (Abruzzi)].
    Pampiglione S
    Parassitologia; 1971; 13(1):231-9. PubMed ID: 5152939
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrence of kala-azar associated with post-kala-azar dermal leishmaniasis.
    Sen Gupta PC; Mukherjee AM
    J Indian Med Assoc; 1968 Jan; 50(1):1-5 passim. PubMed ID: 5668350
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leishmaniasis (kala-azar, oriental sore, South American leishmaniasis)].
    Malamos B
    Wien Z Inn Med; 1967; 48(6):209-21. PubMed ID: 5630155
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mucocutaneous leishmaniasis in otorhinolaryngology].
    Patuano E; Carrat X; Drouet Y; Barnabé D; Vincey P; Berthelot B
    Ann Otolaryngol Chir Cervicofac; 1993; 110(7):415-9. PubMed ID: 8085723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil.
    Amato VS; Tuon FF; Imamura R; Abegão de Camargo R; Duarte MI; Neto VA
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1026-34. PubMed ID: 19453817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of visceral leishmaniasis with a difficult parasitological diagnosis and unexpected complications (author's transl)].
    Gendron Y; Laroche R; Sirol J
    Med Trop (Mars); 1978; 38(4):443-5. PubMed ID: 732560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of leishmaniasis (author's transl)].
    Barabe P
    Med Trop (Mars); 1981; 41(6):599-605. PubMed ID: 7339417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of mucocutaneous leishmaniasis with pentamidine isothionate].
    Amato V; Amato J; Nicodemo A; Uip D; Amato-Neto V; Duarte M
    Ann Dermatol Venereol; 1998 Aug; 125(8):492-5. PubMed ID: 9747313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transitory acute kidney insufficiency and insulin-dependent after treatment of kala-azar with pentamidine and N-methylglucamine antimony].
    Morin D; Dumas ML; Valette H; Dumas R
    Arch Fr Pediatr; 1991 May; 48(5):349-51. PubMed ID: 1859238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ulcerative post-kala azar mucosal leishmaniasis masquerading as a carcinoma--a case report.
    Toran KC; Sah SP; Joshi A; Rani S
    Indian J Pathol Microbiol; 2003 Jul; 46(3):487-9. PubMed ID: 15025319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Visceral and cutaneous leishmaniasis].
    Aulepp H; Gartmann H; Steigleder GK
    Z Hautkr; 1975 May; 50(9):355-64. PubMed ID: 52950
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-kala-azar dermal leishmaniasis.
    Baghestani S; Handjani F; Sodeifi M; Kumar PV
    Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneo-visceral leishmaniasis: a new opportunistic infection in patients infected by HIV].
    Botella Estrada R; Sanmartín Jiménez O; Febrer Bosch MI; Aliaga Boniche A; Salavert Lleti M; Roig Rico P; Nieto García A; Navarro Ibañez V
    Med Cutan Ibero Lat Am; 1990; 18(2):119-23. PubMed ID: 2214938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does the "leishmanian disease" exist? Apropos of the first case of so called sudanese kala-azar in Chad].
    Sirol J; Vedy J
    Nouv Presse Med; 1972 May; 1(20):1337-40. PubMed ID: 5035878
    [No Abstract]   [Full Text] [Related]  

  • 17. A case report of visceral leishmaniasis in the Tharaka District, Kenya.
    Pelizzi M; Verna M; Vanelli M
    Acta Biomed; 2006 Aug; 77(2):103-5. PubMed ID: 17172190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmaniasis of the nose caused by different species of Leishmania in the Sudan. Distinguishing features of the different clinical forms.
    el-Hassan AM; Yagi HI; Zijlstra EE; el-Kadarow AI
    Trop Geogr Med; 1994; 46(1):33-6. PubMed ID: 8165735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of visceral leishmaniasis (Kala-Azar). Side effects during the treatment with pentamidine].
    Lichey J; Linderer T; Dissmann T
    MMW Munch Med Wochenschr; 1979 May; 121(19):665-6. PubMed ID: 112393
    [No Abstract]   [Full Text] [Related]  

  • 20. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.